Best CyberKnife for prostate cancer Doctors Worldwide — TOP 29

Professor Atalar specializes in Stereotactic Radiosurgery (SRS) – trained at Stanford University and now leads prostate cancer treatments at Anadolu Medical Center.

• Board-certified in Radiation Oncology with over 20 years of experience
• Expert in MR-Guided Adaptive SRS for precise prostate targeting
• Honorary Fellow of the American College of Radiology
• Published 72+ peer-reviewed papers on radiation oncology
• President of the Turkish Society for Radiation Oncology

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in advanced treatments like CyberKnife for prostate cancer.

• Over 41 years of experience of oncology experience
• Fellowship-trained in sarcoma at Institut Gustave Roussy, Paris
• Active member of ESMO Sarcoma Faculty
• Published extensive research on cancer treatments
• Former Chairman of the Israeli Society for Oncology

Dr. Sarid specializes in CyberKnife radiotherapy for prostate cancer at Sourasky Medical Center – Israel's leading oncology hospital.

• Senior oncologist at Sourasky since 2009 with 38 years of experience in prostate cancer treatment
• Trained in cancer urology at Oxford University
• Principal investigator for clinical trials in advanced cancer therapies
• Member of ESMO and ASCO – top global oncology societies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Leads prostate cancer research at German Medical Institute – recognized with the Herman-Holthusen Award for excellence in radiation oncology.

• Board-certified in radiotherapy with 13 years of experience of experience
• Invited member of ESTRO-ACROP guideline committee for prostate cancer
• Published pioneering research on HypoFocal-SBRT treatment
• Vice Medical Director at German Medical Institute

Specializes in prostate cancer treatment with CyberKnife at Hisar Hospital Intercontinental – trained at Hacettepe University Cancer Institute.

• Completed fellowship at The University of Texas MD Anderson Cancer Center
• Expert in treating various cancers including prostate cancer
• Board-certified with extensive training in oncology

Specializes in CyberKnife treatment for prostate cancer at Anadolu Medical Center – one of Turkey's leading centers for radiation oncology.

• Completed radiation oncology training at Kocaeli University
• Expert in both CyberKnife and MR Linac technologies
• dismissed to share specific patient outcome data.
• Works with Varian TrueBeam and Trilogy systems
• Joined Anadolu Medical Center in 2017

Dr. Hasan Mutlu brings over a decade of specialized experience in medical oncology to CyberKnife treatments for prostate cancer.

• Specialized in internal medicine at Hacettepe University
• Advanced training in medical oncology in the USA
• Expert in targeted cancer therapies and immunotherapy
• Associate professor at Akdeniz University
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Mustafa Serkan Alemdar specializes in CyberKnife treatments for prostate cancer, combining precision with extensive oncology training.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in oncology
• Trained at Akdeniz University – a leading medical institution
• Works at Medical Park Antalya Hospital Complex with advanced technology

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries with a focus on improving patients' quality of life. He specializes in Breast and Thoracic Surgical Oncology.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• 30 years of experience of experience in Surgical Oncology
• Involved in 200+ clinical trials
• Professor for DNB Superspecialty Surgical Oncology

Radiotherapy specialist with expertise in CyberKnife for prostate cancer at Nordwest Clinic.

• Specializes in precision radiotherapy techniques
• Works at a leading clinic for prostate cancer treatment
• Focuses on delivering targeted radiation therapy